Replies to post #539393 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

They should try an additional arm with Pembrolizumab 100** mg q 6 weeks with the DC and CSF1R combination.
It’s just stupid not to try and reduce toxicity, when they know the combination is synergistic. Pembro toxicity prevents too many people from receiving treatment. Imo.

**Instead of 400mg

[ATLnsider]

Thanks Lykiri, do you have a link for these statements?

Also, did you watch the video I linked for Dr. Liau’s May 2021 presentation? Do you think she misspoke when she said Bristol Myers Squibb (BMS), or do you believe her plans changed?

[ATLnsider]

Lykiri, never mind, I believe I have found the link you quoted. But, I would still like for you to answer the 2 questions I posed.

Also, I found this link below for the DCVax-L + Nivolumab + CFR-1R study for the UCLA + Bristol Myers Squibb (BMS) collaboration it appears that the NIH also provided some funding for this study, and the money was budgeted and expended by UCLA:

https://reporter.nih.gov/search/cmeOHFTNlEGR3qDo7Efd5Q/project-details/9983047